Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,948 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The way forward for ETEC controlled human infection models (CHIMs).
Hanevik K, Chen WH, Talaat KR, Porter C, Bourgeois L. Hanevik K, et al. Among authors: porter c. Vaccine. 2019 Aug 7;37(34):4794-4799. doi: 10.1016/j.vaccine.2019.01.003. Epub 2019 Jan 29. Vaccine. 2019. PMID: 30709728 Free article. Review.
Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.
Lapa JA, Sincock SA, Ananthakrishnan M, Porter CK, Cassels FJ, Brinkley C, Hall ER, van Hamont J, Gramling JD, Carpenter CM, Baqar S, Tribble DR. Lapa JA, et al. Among authors: porter ck. Clin Vaccine Immunol. 2008 Aug;15(8):1222-8. doi: 10.1128/CVI.00491-07. Epub 2008 Jun 25. Clin Vaccine Immunol. 2008. PMID: 18579693 Free PMC article. Clinical Trial.
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.
Riddle MS, Kaminski RW, Williams C, Porter C, Baqar S, Kordis A, Gilliland T, Lapa J, Coughlin M, Soltis C, Jones E, Saunders J, Keiser PB, Ranallo RT, Gormley R, Nelson M, Turbyfill KR, Tribble D, Oaks EV. Riddle MS, et al. Among authors: porter c. Vaccine. 2011 Sep 16;29(40):7009-19. doi: 10.1016/j.vaccine.2011.07.033. Epub 2011 Jul 23. Vaccine. 2011. PMID: 21787825 Clinical Trial.
Developing and utilizing controlled human models of infection.
Porter CK, Louis Bourgeois A, Frenck RW, Prouty M, Maier N, Riddle MS. Porter CK, et al. Vaccine. 2017 Dec 14;35(49 Pt A):6813-6818. doi: 10.1016/j.vaccine.2017.05.068. Epub 2017 Jun 3. Vaccine. 2017. PMID: 28583306 Free article.
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.
Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, Jaep K, Alcala A, Mochalova Y, Gariepy CL, Chakraborty S, Guerry P, Tribble DR, Porter CK, Riddle MS. Rimmer JE, et al. Among authors: porter ck. Clin Infect Dis. 2018 Apr 17;66(9):1435-1441. doi: 10.1093/cid/cix1014. Clin Infect Dis. 2018. PMID: 29145631 Clinical Trial.
1,948 results